Alpha Centric Advisors LLC Dynavax Technologies Corp Transaction History
Alpha Centric Advisors LLC
- $144 Million
- Q1 2024
A detailed history of Alpha Centric Advisors LLC transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 122,500 shares of DVAX stock, worth $1.34 Million. This represents 1.05% of its overall portfolio holdings.
Number of Shares
122,500
Previous 100,000
22.5%
Holding current value
$1.34 Million
Previous $1.4 Million
8.73%
% of portfolio
1.05%
Previous 1.09%
Shares
9 transactions
Others Institutions Holding DVAX
# of Institutions
267Shares Held
132MCall Options Held
326KPut Options Held
758K-
Black Rock Inc. New York, NY23.2MShares$253 Million0.01% of portfolio
-
State Street Corp Boston, MA10.6MShares$116 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.4MShares$103 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.14MShares$99.8 Million3.75% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA7.99MShares$87.2 Million0.23% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.38B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...